control:radiotherapy

2 trials

Sponsors

West China Hospital, Sichuan University, Sir Run Run Shaw Hospital of Zhejiang University School of Medicine

Conditions

High-Risk Low-Grade Gliomasesophageal carcinoma

Phase 1

Short-term efficacy fety of high dose nimotuzumab in combination with concurrent chemoradiationas first-line treatment for patientswith local advanced esophageal squamous cell carcinoma : A Multicenter Study.

Active, not recruitingChiCTR-IPR-15007059

Sir Run Run Shaw Hospital of Zhejiang University School of Medicineesophageal carcinoma

Start: 2015-10-01Updated: 2017-04-18

Phase 2

Randomized Controlled Trial of Radiation Therapy versus Radiation Therapy Plus Temozolomide for High-Risk Low-Grade Gliomas

RecruitingChiCTR1800015199

West China Hospital, Sichuan UniversityHigh-Risk Low-Grade Gliomas

Start: 2018-06-01Updated: 2018-12-10

Related Papers

Radiotherapy versus radiotherapy combined with temozolomide in high-risk low-grade gliomas after surgery: study protocol for a randomized controlled clinical trial.

2019-11-217 citations